{
    "title": "Domestic Chemical Diversion Control Act of 1993",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Domestic Chemical Diversion Control \nAct of 1993''.\n\nSEC. 2. DEFINITION AMENDMENTS.\n\n    (a) Definitions.--Section 102 of the Controlled Substances Act (21 \nU.S.C. 802) is amended--\n            (1) in paragraph (33), by striking ``any listed precursor \n        chemical or listed essential chemical'' and inserting ``any \n        list I chemical or any list II chemical'';\n            (2) in paragraph (34)--\n                    (A) by striking ``listed precursor chemical'' and \n                inserting ``list I chemical''; and\n                    (B) by striking ``critical to the creation'' and \n                inserting ``important to the manufacture'';\n            (3) in paragraph (34)(A), (F), and (H), by inserting ``, \n        its esters,'' before ``and'';\n            (4) in paragraph (35)--\n                    (A) by striking ``listed essential chemical'' and \n                inserting ``list II chemical'';\n                    (B) by inserting ``(other than a list I chemical)'' \n                before ``specified''; and\n                    (C) by striking ``as a solvent, reagent, or \n                catalyst''; and\n            (5) in paragraph (38), by inserting ``or who acts as a \n        broker or trader for an international transaction involving a \n        listed chemical, a tableting machine, or an encapsulating \n        machine'' before the period;\n            (6) in paragraph (39)(A)--\n                    (A) by striking ``importation or exportation of'' \n                and inserting ``importation, or exportation of, or an \n                international transaction involving shipment of,'';\n                    (B) in clause (iii) by inserting ``or any category \n                of transaction for a specific listed chemical or \n                chemicals'' after ``transaction'';\n                    (C) by amending clause (iv) to read as follows:\n                    ``(iv) any transaction in a listed chemical that is \n                contained in a drug that may be marketed or distributed \n                lawfully in the United States under the Federal Food, \n                Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) unless--\n                            ``(I)(aa) the drug contains ephedrine or \n                        its salts, optical isomers, or salts of optical \n                        isomers as the only active medicinal ingredient \n                        or contains ephedrine or its salts, optical \n                        isomers, or salts of optical isomers and \n                        therapeutically insignificant quantities of \n                        another active medicinal ingredient; or\n                            ``(bb) the Attorney General has determined \n                        under section 204 that the drug or group of \n                        drugs is being diverted to obtain the listed \n                        chemical for use in the illicit production of a \n                        controlled substance; and\n                            ``(II) the quantity of ephedrine or other \n                        listed chemical contained in the drug included \n                        in the transaction or multiple transactions \n                        equals or exceeds the threshold established for \n                        that chemical by the Attorney General.''; and\n                    (D) in clause (v), by striking the semicolon and \n                inserting ``which the Attorney General has by \n                regulation designated as exempt from the application of \n                this title and title II based on a finding that the \n                mixture is formulated in such a way that it cannot be \n                easily used in the illicit production of a controlled \n                substance and that the listed chemical or chemicals \n                contained in the mixture cannot be readily \n                recovered;'';\n            (7) in paragraph (40), by striking ``listed precursor \n        chemical or a listed essential chemical'' each place it appears \n        and inserting ``list I chemical or a list II chemical''; and\n            (8) by adding at the end the following new paragraphs:\n    ``(42) The term `international transaction' means a transaction \ninvolving the shipment of a listed chemical across an international \nborder (other than a United States border) in which a broker or trader \nlocated in the United States participates.\n    ``(43) The terms `broker' and `trader' mean a person that assists \nin arranging an international transaction in a listed chemical by--\n            ``(A) negotiating contracts;\n            ``(B) serving as an agent or intermediary; or\n            ``(C) bringing together a buyer and seller, a buyer and \n        transporter, or a seller and transporter.''.\n    (b) Removal of Exemption of Certain Drugs.--\n            (1) Procedure.--Part B of the Controlled Substances Act (21 \n        U.S.C. 811 et seq.) is amended by adding at the end the \n        following new section:\n\n                ``removal of exemption of certain drugs\n\n    ``Sec. 204. (a) Removal of Exemption.--The Attorney General shall \nby regulation remove from exemption under section 102(39)(A)(iv) a drug \nor group of drugs that the Attorney General finds is being diverted to \nobtain a listed chemical for use in the illicit production of a \ncontrolled substance.\n    ``(b) Factors To Be Considered.--In removing a drug or group of \ndrugs from exemption under subsection (a), the Attorney General shall \nconsider, with respect to a drug or group of drugs that is proposed to \nbe removed from exemption--\n            ``(1) the scope, duration, and significance of the \n        diversion;\n            ``(2) whether the drug or group of drugs is formulated in \n        such a way that it cannot be easily used in the illicit \n        production of a controlled substance; and\n            ``(3) whether the listed chemical can be readily recovered \n        from the drug or group of drugs.\n    ``(c) Specificity of Designation.--The Attorney General shall limit \nthe designation of a drug or a group of drugs removed from exemption \nunder subsection (a) to the most particularly identifiable type of drug \nor group of drugs for which evidence of diversion exists unless there \nis evidence, based on the pattern of diversion and other relevant \nfactors, that the diversion will not be limited to that particular drug \nor group of drugs.\n    ``(d) Reinstatement of Exemption With Respect to Particular Drug \nProducts.--\n            ``(1) Reinstatement.--On application by a manufacturer of a \n        particular drug product that has been removed from exemption \n        under subsection (a), the Attorney General shall by regulation \n        reinstate the exemption with respect to that particular drug \n        product if the Attorney General determines that the particular \n        drug product is manufactured and distributed in a manner that \n        prevents diversion.\n            ``(2) Factors to be considered.--In deciding whether to \n        reinstate the exemption with respect to a particular drug \n        product under paragraph (1), the Attorney General shall \n        consider--\n                    ``(A) the package sizes and manner of packaging of \n                the drug product;\n                    ``(B) the manner of distribution and advertising of \n                the drug product;\n                    ``(C) evidence of diversion of the drug product;\n                    ``(D) any actions taken by the manufacturer to \n                prevent diversion of the drug product; and\n                    ``(E) such other factors as are relevant to and \n                consistent with the public health and safety, including \n                the factors described in subsection (b) as applied to \n                the drug product.\n            ``(3) Status pending application for reinstatement.--A \n        transaction involving a particular drug product that is the \n        subject of a bona fide pending application for reinstatement of \n        exemption filed with the Attorney General not later than 60 \n        days after a regulation removing the exemption is issued \n        pursuant to subsection (a) shall not be considered to be a \n        regulated transaction if the transaction occurs during the \n        pendency of the application and, if the Attorney General denies \n        the application, during the period of 60 days following the \n        date on which the Attorney General denies the application, \n        unless--\n                    ``(A) the Attorney General has evidence that, \n                applying the factors described in subsection (b) to the \n                drug product, the drug product is being diverted; and\n                    ``(B) the Attorney General so notifies the \n                applicant.\n            ``(4) Amendment and modification.--A regulation reinstating \n        an exemption under paragraph (1) may be modified or revoked \n        with respect to a particular drug product upon a finding that--\n                    ``(A) applying the factors described in subsection \n                (b) to the drug product, the drug product is being \n                diverted; or\n                    ``(B) there is a significant change in the data \n                that led to the issuance of the regulation.''.\n            (2) Clerical amendment.--The table of contents of the \n        Comprehensive Drug Abuse Prevention and Control Act of 1970 (84 \n        Stat. 1236) is amended by adding at the end of that portion \n        relating to part B of title II the following new item:\n\n``Sec. 204. Removal of exemption of certain drugs.''.\n    (c) Regulation of Listed Chemicals.--Section 310 of the Controlled \nSubstances Act (21 U.S.C. 830) is amended--\n            (1) in subsection (a)(1)--\n                    (A) by striking ``precursor chemical'' and \n                inserting ``list I chemical''; and\n                    (B) in subparagraph (B), by striking ``an essential \n                chemical'' and inserting ``a list II chemical''; and\n            (2) in subsection (c)(2)(D), by striking ``precursor \n        chemical'' and inserting ``chemical control''.\n\nSEC. 3. REGISTRATION REQUIREMENTS.\n\n    (a) Rules and Regulations.--Section 301 of the Controlled \nSubstances Act (21 U.S.C. 821) is amended by striking the period and \ninserting ``and to the registration and control of regulated persons \nand of regulated transactions.''.\n    (b) Persons Required To Register Under Section 302.--Section 302 of \nthe Controlled Substances Act (21 U.S.C. 822) is amended--\n            (1) in subsection (a)(1), by inserting ``or list I \n        chemical'' after ``controlled substance'' each place it \n        appears;\n            (2) in subsection (b)--\n                    (A) by inserting ``or list I chemicals'' after \n                ``controlled substances''; and\n                    (B) by inserting ``or chemicals'' after ``such \n                substances'';\n            (3) in subsection (c), by inserting ``or list I chemical'' \n        after ``controlled substance'' each place it appears; and\n            (4) in subsection (e), by inserting ``or list I chemicals'' \n        after ``controlled substances''.\n    (c) Registration Requirements Under Section 303.--Section 303 of \nthe Controlled Substances Act (21 U.S.C. 823) is amended by adding at \nthe end the following new subsection:\n    ``(h) The Attorney General shall register an applicant to \ndistribute a list I chemical unless the Attorney General determines \nthat registration of the applicant is inconsistent with the public \ninterest. Registration under this subsection shall not be required for \nthe distribution of a drug product that is exempted under section \n102(39)(A)(iv). In determining the public interest for the purposes of \nthis subsection, the Attorney General shall consider--\n            ``(1) maintenance by the applicant of effective controls \n        against diversion of listed chemicals into other than \n        legitimate channels;\n            ``(2) compliance by the applicant with applicable Federal, \n        State, and local law;\n            ``(3) any prior conviction record of the applicant under \n        Federal or State laws relating to controlled substances or to \n        chemicals controlled under Federal or State law;\n            ``(4) any past experience of the applicant in the \n        manufacture and distribution of chemicals; and\n            ``(5) such other factors as are relevant to and consistent \n        with the public health and safety.''.\n    (d) Denial, Revocation, or Suspension of Registration.--Section 304 \nof the Controlled Substances Act (21 U.S.C. 824) is amended--\n            (1) in subsection (a)--\n                    (A) by inserting ``or a list I chemical'' after \n                ``controlled substance'' each place it appears; and\n                    (B) by inserting ``or list I chemicals'' after \n                ``controlled substances'';\n            (2) in subsection (b), by inserting ``or list I chemical'' \n        after ``controlled substance'';\n            (3) in subsection (f), by inserting ``or list I chemicals'' \n        after ``controlled substances'' each place it appears; and\n            (4) in subsection (g)--\n                    (A) by inserting ``or list I chemicals'' after \n                ``controlled substances'' each place it appears; and\n                    (B) by inserting ``or list I chemical'' after \n                ``controlled substance'' each place it appears.\n    (e) Persons Required To Register Under Section 1007.--Section 1007 \nof the Controlled Substances Import and Export Act (21 U.S.C. 957) is \namended--\n            (1) in subsection (a)--\n                    (A) in paragraph (1), by inserting ``or list I \n                chemical'' after ``controlled substance''; and\n                    (B) in paragraph (2), by striking ``in schedule I, \n                II, III, IV, or V,'' and inserting ``or list I \n                chemical,''; and\n            (2) in subsection (b)--\n                    (A) in paragraph (1), by inserting ``or list I \n                chemical'' after ``controlled substance'' each place it \n                appears; and\n                    (B) in paragraph (2), by inserting ``or list I \n                chemicals'' after ``controlled substances''.\n    (f) Registration Requirements Under Section 1008.--Section 1008 of \nthe Controlled Substances Import and Export Act (21 U.S.C. 958) is \namended--\n            (1) in subsection (c)--\n                    (A) by inserting ``(1)'' after ``(c)''; and\n                    (B) by adding at the end the following new \n                paragraph:\n    ``(2)(A) The Attorney General shall register an applicant to import \nor export a list I chemical unless the Attorney General determines that \nregistration of the applicant is inconsistent with the public interest. \nRegistration under this subsection shall not be required for the import \nor export of a drug product that is exempted under section \n102(39)(A)(iv).\n    ``(B) In determining the public interest for the purposes of \nsubparagraph (A), the Attorney General shall consider the factors \nspecified in section 303(h).'';\n            (2) in subsection (d)--\n                    (A) in paragraph (3), by inserting ``or list I \n                chemical or chemicals,'' after ``substances,''; and\n                    (B) in paragraph (6), by inserting ``or list I \n                chemicals'' after ``controlled substances'' each place \n                it appears;\n            (3) in subsection (e), by striking ``and 307'' and \n        inserting ``307, and 310''; and\n            (4) in subsections (f), (g), and (h), by inserting ``or \n        list I chemicals'' after ``controlled substances'' each place \n        it appears.\n    (g) Prohibited Acts C.--Section 403(a) of the Controlled Substances \nAct (21 U.S.C. 843(a)) is amended--\n            (1) by amending paragraphs (6) and (7) to read as follows:\n            ``(6) to possess any three-neck round-bottom flask, \n        tableting machine, encapsulating machine, or gelatin capsule, \n        or any equipment, chemical, product, or material which may be \n        used to manufacture a controlled substance or listed chemical, \n        knowing, intending, or having reasonable cause to believe, that \n        it will be used to manufacture a controlled substance or listed \n        chemical in violation of this title or title II;\n            ``(7) to manufacture, distribute, export, or import any \n        three-neck round-bottom flask, tableting machine, encapsulating \n        machine, or gelatin capsule, or any equipment, chemical, \n        product, or material which may be used to manufacture a \n        controlled substance or listed chemical, knowing, intending, or \n        having reasonable cause to believe, that it will be used to \n        manufacture a controlled substance or listed chemical in \n        violation of this title or title II or, in the case of an \n        exportation, in violation of this title or title II or of the \n        laws of the country to which it is exported;'';\n            (2) by striking the period at the end of paragraph (8) and \n        inserting ``; or''; and\n            (3) by adding at the end the following new paragraph:\n            ``(9) if the person is a regulated person, to distribute, \n        import, or export a list I chemical without the registration \n        required by this Act.''.\n\nSEC. 4. ANTI-SMUGGLING PROVISION.\n\n    Section 1010(d) of the Controlled Substances Import and Export Act \n(21 U.S.C. 960(d)) is amended--\n            (1) by striking ``or'' at the end of paragraph (1); and\n            (2) by adding at the end the following new paragraph:\n            ``(3) imports or exports a listed chemical in violation of \n        section 1007 or 1018,''.\n\nSEC. 5. ADMINISTRATIVE INSPECTIONS AND AUTHORITY.\n\n    Section 510 of the Controlled Substances Act (21 U.S.C. 880) is \namended--\n            (1) by amending subsection (a)(2) to read as follows:\n            ``(2) places, including factories, warehouses, and other \n        establishments, and conveyances, where persons registered under \n        section 303 (or exempt from registration under section 302(d) \n        or by regulation of the Attorney General) or regulated persons \n        may lawfully hold, manufacture, distribute, dispense, \n        administer, or otherwise dispose of controlled substances or \n        listed chemicals or where records relating to those activities \n        are maintained.''; and\n            (2) in subsection (b)(3)--\n                    (A) in subparagraph (B), by inserting ``, listed \n                chemicals,'' after ``unfinished drugs''; and\n                    (B) in subparagraph (C), by inserting ``or listed \n                chemical'' after ``controlled substance'' and inserting \n                ``or chemical'' after ``such substance''.\n\nSEC. 6. FORFEITURE EXPANSION.\n\n    Section 511(a)(6) of the Controlled Substances Act (21 U.S.C. \n881(a)(6)) is amended by inserting ``or listed chemical'' after \n``controlled substance''.\n\nSEC. 7. THRESHOLD AMOUNTS.\n\n    Section 102(39)(A) of the Controlled Substances Act (21 U.S.C. \n802(39)(A)), as amended by section 2, is amended by inserting ``a \nlisted chemical, or if the Attorney General establishes a threshold \namount for a specific listed chemical,'' before ``a threshold amount, \nincluding a cumulative threshold amount for multiple transactions''.\n\nSEC. 8. EFFECTIVE DATE.\n\n    This Act and the amendments made by this Act shall take effect on \nthe date that is 120 days after the date of enactment of this Act.\n\n                                 \n\nS 1663 IS----2\nS 1663 IS----3"
}